nodes	percent_of_prediction	percent_of_DWPC	metapath
Olopatadine—Histamine H1 Receptor Antagonists—Diphenhydramine—atopic dermatitis	0.386	1	CiPCiCtD
Olopatadine—allergic rhinitis—atopic dermatitis	0.326	1	CtDrD
Olopatadine—HRH1—Dimenhydrinate—atopic dermatitis	0.0324	0.325	CbGbCtD
Olopatadine—Doxepin—Diphenhydramine—atopic dermatitis	0.0264	0.227	CrCrCtD
Olopatadine—Cyclobenzaprine—Diphenhydramine—atopic dermatitis	0.0248	0.214	CrCrCtD
Olopatadine—Dimetindene—Diphenhydramine—atopic dermatitis	0.0241	0.208	CrCrCtD
Olopatadine—Amitriptyline—Diphenhydramine—atopic dermatitis	0.0222	0.192	CrCrCtD
Olopatadine—Imipramine—Diphenhydramine—atopic dermatitis	0.0185	0.159	CrCrCtD
Olopatadine—HRH1—Loratadine—atopic dermatitis	0.0158	0.158	CbGbCtD
Olopatadine—HRH1—Diphenhydramine—atopic dermatitis	0.0158	0.158	CbGbCtD
Olopatadine—CYP3A4—Pimecrolimus—atopic dermatitis	0.00922	0.0924	CbGbCtD
Olopatadine—CYP3A4—Tacrolimus—atopic dermatitis	0.00548	0.055	CbGbCtD
Olopatadine—S100A2—skin epidermis—atopic dermatitis	0.00408	0.261	CbGeAlD
Olopatadine—CYP3A4—Loratadine—atopic dermatitis	0.00401	0.0402	CbGbCtD
Olopatadine—CYP3A4—Methylprednisolone—atopic dermatitis	0.00367	0.0368	CbGbCtD
Olopatadine—CYP3A4—Triamcinolone—atopic dermatitis	0.00278	0.0279	CbGbCtD
Olopatadine—CYP3A4—Betamethasone—atopic dermatitis	0.00239	0.0239	CbGbCtD
Olopatadine—CYP3A4—Prednisolone—atopic dermatitis	0.00235	0.0236	CbGbCtD
Olopatadine—CYP3A4—Hydrocortisone—atopic dermatitis	0.00223	0.0224	CbGbCtD
Olopatadine—CYP3A4—Prednisone—atopic dermatitis	0.00222	0.0223	CbGbCtD
Olopatadine—S100A1—neck—atopic dermatitis	0.0018	0.115	CbGeAlD
Olopatadine—S100A13—neck—atopic dermatitis	0.0016	0.102	CbGeAlD
Olopatadine—CYP3A4—Dexamethasone—atopic dermatitis	0.00139	0.0139	CbGbCtD
Olopatadine—S100A2—skin of body—atopic dermatitis	0.00126	0.0807	CbGeAlD
Olopatadine—S100A1—skin of body—atopic dermatitis	0.00116	0.0744	CbGeAlD
Olopatadine—S100A13—skin of body—atopic dermatitis	0.00103	0.066	CbGeAlD
Olopatadine—S100B—skin of body—atopic dermatitis	0.00101	0.0642	CbGeAlD
Olopatadine—S100A2—head—atopic dermatitis	0.000825	0.0527	CbGeAlD
Olopatadine—S100A1—head—atopic dermatitis	0.00076	0.0485	CbGeAlD
Olopatadine—S100A13—head—atopic dermatitis	0.000674	0.043	CbGeAlD
Olopatadine—S100A12—head—atopic dermatitis	0.000665	0.0425	CbGeAlD
Olopatadine—S100B—head—atopic dermatitis	0.000656	0.0419	CbGeAlD
Olopatadine—HRH1—head—atopic dermatitis	0.000135	0.0086	CbGeAlD
Olopatadine—S100A12—Toll-Like Receptors Cascades—TLR2—atopic dermatitis	0.000134	0.00918	CbGpPWpGaD
Olopatadine—S100A12—TRAF6 Mediated Induction of proinflammatory cytokines—NFKBIA—atopic dermatitis	0.00013	0.00894	CbGpPWpGaD
Olopatadine—S100B—Toll-Like Receptors Cascades—TLR2—atopic dermatitis	0.000127	0.00868	CbGpPWpGaD
Olopatadine—S100A12—RIG-I/MDA5 mediated induction of IFN-alpha/beta pathways—NFKBIA—atopic dermatitis	0.000124	0.00849	CbGpPWpGaD
Olopatadine—S100B—TRAF6 Mediated Induction of proinflammatory cytokines—NFKBIA—atopic dermatitis	0.000123	0.00845	CbGpPWpGaD
Olopatadine—S100A12—MyD88 cascade initiated on plasma membrane—NFKBIA—atopic dermatitis	0.000118	0.00809	CbGpPWpGaD
Olopatadine—S100B—RIG-I/MDA5 mediated induction of IFN-alpha/beta pathways—NFKBIA—atopic dermatitis	0.000117	0.00803	CbGpPWpGaD
Olopatadine—S100A12—TRAF6 mediated induction of NFkB and MAP kinases upon TLR7/8 or 9 activation—NFKBIA—atopic dermatitis	0.000117	0.00801	CbGpPWpGaD
Olopatadine—S100A12—MyD88 dependent cascade initiated on endosome—NFKBIA—atopic dermatitis	0.000115	0.00787	CbGpPWpGaD
Olopatadine—S100A12—Innate Immune System—FCER1A—atopic dermatitis	0.000112	0.0077	CbGpPWpGaD
Olopatadine—S100A12—RIG-I/MDA5 mediated induction of IFN-alpha/beta pathways—CASP8—atopic dermatitis	0.000112	0.00766	CbGpPWpGaD
Olopatadine—S100B—MyD88 cascade initiated on plasma membrane—NFKBIA—atopic dermatitis	0.000112	0.00765	CbGpPWpGaD
Olopatadine—HRH1—IL-4 Signaling Pathway—STAT6—atopic dermatitis	0.000111	0.00762	CbGpPWpGaD
Olopatadine—S100A12—Toll Like Receptor 9 (TLR9) Cascade—NFKBIA—atopic dermatitis	0.000111	0.00759	CbGpPWpGaD
Olopatadine—S100B—TRAF6 mediated induction of NFkB and MAP kinases upon TLR7/8 or 9 activation—NFKBIA—atopic dermatitis	0.000111	0.00758	CbGpPWpGaD
Olopatadine—S100A12—MyD88:Mal cascade initiated on plasma membrane—NFKBIA—atopic dermatitis	0.000109	0.00746	CbGpPWpGaD
Olopatadine—S100B—MyD88 dependent cascade initiated on endosome—NFKBIA—atopic dermatitis	0.000109	0.00744	CbGpPWpGaD
Olopatadine—S100B—Innate Immune System—FCER1A—atopic dermatitis	0.000106	0.00729	CbGpPWpGaD
Olopatadine—S100A12—Immune System—CTSE—atopic dermatitis	0.000106	0.00726	CbGpPWpGaD
Olopatadine—S100B—RIG-I/MDA5 mediated induction of IFN-alpha/beta pathways—CASP8—atopic dermatitis	0.000106	0.00724	CbGpPWpGaD
Olopatadine—S100B—Toll Like Receptor 9 (TLR9) Cascade—NFKBIA—atopic dermatitis	0.000105	0.00718	CbGpPWpGaD
Olopatadine—S100A12—Innate Immune System—MS4A2—atopic dermatitis	0.000105	0.00716	CbGpPWpGaD
Olopatadine—S100A12—MyD88-independent cascade—NFKBIA—atopic dermatitis	0.000104	0.00716	CbGpPWpGaD
Olopatadine—S100B—MyD88:Mal cascade initiated on plasma membrane—NFKBIA—atopic dermatitis	0.000103	0.00706	CbGpPWpGaD
Olopatadine—S100B—Immune System—CTSE—atopic dermatitis	0.0001	0.00687	CbGpPWpGaD
Olopatadine—S100B—Innate Immune System—MS4A2—atopic dermatitis	9.88e-05	0.00677	CbGpPWpGaD
Olopatadine—S100B—MyD88-independent cascade—NFKBIA—atopic dermatitis	9.88e-05	0.00677	CbGpPWpGaD
Olopatadine—S100A12—MyD88-independent cascade—CASP8—atopic dermatitis	9.42e-05	0.00646	CbGpPWpGaD
Olopatadine—S100A12—Activated TLR4 signalling—NFKBIA—atopic dermatitis	9.4e-05	0.00644	CbGpPWpGaD
Olopatadine—S100A12—Innate Immune System—DEFB1—atopic dermatitis	9.32e-05	0.00638	CbGpPWpGaD
Olopatadine—S100B—MyD88-independent cascade—CASP8—atopic dermatitis	8.91e-05	0.00611	CbGpPWpGaD
Olopatadine—S100B—Activated TLR4 signalling—NFKBIA—atopic dermatitis	8.89e-05	0.00609	CbGpPWpGaD
Olopatadine—S100A12—Toll Like Receptor 4 (TLR4) Cascade—NFKBIA—atopic dermatitis	8.84e-05	0.00606	CbGpPWpGaD
Olopatadine—S100B—Innate Immune System—DEFB1—atopic dermatitis	8.81e-05	0.00604	CbGpPWpGaD
Olopatadine—S100A12—Activated TLR4 signalling—CASP8—atopic dermatitis	8.48e-05	0.00581	CbGpPWpGaD
Olopatadine—S100B—Toll Like Receptor 4 (TLR4) Cascade—NFKBIA—atopic dermatitis	8.36e-05	0.00573	CbGpPWpGaD
Olopatadine—S100A12—TRAF6 Mediated Induction of proinflammatory cytokines—MAPK8—atopic dermatitis	8.18e-05	0.00561	CbGpPWpGaD
Olopatadine—S100B—Activated TLR4 signalling—CASP8—atopic dermatitis	8.02e-05	0.00549	CbGpPWpGaD
Olopatadine—S100A12—Toll Like Receptor 4 (TLR4) Cascade—CASP8—atopic dermatitis	7.97e-05	0.00546	CbGpPWpGaD
Olopatadine—S100A12—Toll-Like Receptors Cascades—NFKBIA—atopic dermatitis	7.87e-05	0.0054	CbGpPWpGaD
Olopatadine—S100B—TRAF6 Mediated Induction of proinflammatory cytokines—MAPK8—atopic dermatitis	7.74e-05	0.0053	CbGpPWpGaD
Olopatadine—S100B—Toll Like Receptor 4 (TLR4) Cascade—CASP8—atopic dermatitis	7.54e-05	0.00517	CbGpPWpGaD
Olopatadine—S100B—Toll-Like Receptors Cascades—NFKBIA—atopic dermatitis	7.45e-05	0.0051	CbGpPWpGaD
Olopatadine—S100A12—MyD88 cascade initiated on plasma membrane—MAPK8—atopic dermatitis	7.4e-05	0.00507	CbGpPWpGaD
Olopatadine—S100A12—TRAF6 mediated induction of NFkB and MAP kinases upon TLR7/8 or 9 activation—MAPK8—atopic dermatitis	7.34e-05	0.00503	CbGpPWpGaD
Olopatadine—S100A12—MyD88 dependent cascade initiated on endosome—MAPK8—atopic dermatitis	7.2e-05	0.00494	CbGpPWpGaD
Olopatadine—S100A12—Toll-Like Receptors Cascades—CASP8—atopic dermatitis	7.1e-05	0.00487	CbGpPWpGaD
Olopatadine—S100B—MyD88 cascade initiated on plasma membrane—MAPK8—atopic dermatitis	7e-05	0.0048	CbGpPWpGaD
Olopatadine—S100A12—Toll Like Receptor 9 (TLR9) Cascade—MAPK8—atopic dermatitis	6.95e-05	0.00476	CbGpPWpGaD
Olopatadine—S100B—TRAF6 mediated induction of NFkB and MAP kinases upon TLR7/8 or 9 activation—MAPK8—atopic dermatitis	6.94e-05	0.00475	CbGpPWpGaD
Olopatadine—S100A12—MyD88:Mal cascade initiated on plasma membrane—MAPK8—atopic dermatitis	6.83e-05	0.00468	CbGpPWpGaD
Olopatadine—S100B—MyD88 dependent cascade initiated on endosome—MAPK8—atopic dermatitis	6.81e-05	0.00467	CbGpPWpGaD
Olopatadine—S100B—Toll-Like Receptors Cascades—CASP8—atopic dermatitis	6.72e-05	0.0046	CbGpPWpGaD
Olopatadine—S100B—Toll Like Receptor 9 (TLR9) Cascade—MAPK8—atopic dermatitis	6.57e-05	0.0045	CbGpPWpGaD
Olopatadine—S100A12—MyD88-independent cascade—MAPK8—atopic dermatitis	6.55e-05	0.00449	CbGpPWpGaD
Olopatadine—S100A12—Immune System—FCER1A—atopic dermatitis	6.55e-05	0.00449	CbGpPWpGaD
Olopatadine—S100B—MyD88:Mal cascade initiated on plasma membrane—MAPK8—atopic dermatitis	6.46e-05	0.00443	CbGpPWpGaD
Olopatadine—S100A12—Innate Immune System—STAT6—atopic dermatitis	6.33e-05	0.00434	CbGpPWpGaD
Olopatadine—S100B—MyD88-independent cascade—MAPK8—atopic dermatitis	6.2e-05	0.00425	CbGpPWpGaD
Olopatadine—S100B—Immune System—FCER1A—atopic dermatitis	6.19e-05	0.00424	CbGpPWpGaD
Olopatadine—S100A12—Innate Immune System—CARD11—atopic dermatitis	6.16e-05	0.00422	CbGpPWpGaD
Olopatadine—S100A12—Immune System—MS4A2—atopic dermatitis	6.09e-05	0.00417	CbGpPWpGaD
Olopatadine—S100B—Innate Immune System—STAT6—atopic dermatitis	5.99e-05	0.0041	CbGpPWpGaD
Olopatadine—S100A12—Activated TLR4 signalling—MAPK8—atopic dermatitis	5.9e-05	0.00404	CbGpPWpGaD
Olopatadine—S100B—Innate Immune System—CARD11—atopic dermatitis	5.83e-05	0.00399	CbGpPWpGaD
Olopatadine—S100B—Immune System—MS4A2—atopic dermatitis	5.76e-05	0.00394	CbGpPWpGaD
Olopatadine—HRH1—IL-4 Signaling Pathway—IL4—atopic dermatitis	5.69e-05	0.0039	CbGpPWpGaD
Olopatadine—S100B—Activated TLR4 signalling—MAPK8—atopic dermatitis	5.58e-05	0.00382	CbGpPWpGaD
Olopatadine—S100A12—Toll Like Receptor 4 (TLR4) Cascade—MAPK8—atopic dermatitis	5.55e-05	0.0038	CbGpPWpGaD
Olopatadine—S100A12—Immune System—DEFB1—atopic dermatitis	5.43e-05	0.00372	CbGpPWpGaD
Olopatadine—Body temperature increased—Fluocinolone Acetonide—atopic dermatitis	5.34e-05	0.00127	CcSEcCtD
Olopatadine—Unspecified disorder of skin and subcutaneous tissue—Tacrolimus—atopic dermatitis	5.32e-05	0.00126	CcSEcCtD
Olopatadine—Influenza—Triamcinolone—atopic dermatitis	5.3e-05	0.00126	CcSEcCtD
Olopatadine—Discomfort—Tacrolimus—atopic dermatitis	5.29e-05	0.00126	CcSEcCtD
Olopatadine—Gastrointestinal pain—Mometasone—atopic dermatitis	5.27e-05	0.00125	CcSEcCtD
Olopatadine—Weight increased—Prednisolone—atopic dermatitis	5.25e-05	0.00125	CcSEcCtD
Olopatadine—S100B—Toll Like Receptor 4 (TLR4) Cascade—MAPK8—atopic dermatitis	5.24e-05	0.00359	CbGpPWpGaD
Olopatadine—Dry mouth—Tacrolimus—atopic dermatitis	5.24e-05	0.00124	CcSEcCtD
Olopatadine—Upper respiratory tract infection—Hydrocortisone—atopic dermatitis	5.23e-05	0.00124	CcSEcCtD
Olopatadine—S100A12—TRAF6 Mediated Induction of proinflammatory cytokines—IL6—atopic dermatitis	5.23e-05	0.00358	CbGpPWpGaD
Olopatadine—Diarrhoea—Loratadine—atopic dermatitis	5.14e-05	0.00122	CcSEcCtD
Olopatadine—Oedema—Tacrolimus—atopic dermatitis	5.13e-05	0.00122	CcSEcCtD
Olopatadine—S100B—Immune System—DEFB1—atopic dermatitis	5.13e-05	0.00352	CbGpPWpGaD
Olopatadine—Weight increased—Hydrocortisone—atopic dermatitis	5.12e-05	0.00122	CcSEcCtD
Olopatadine—Dry skin—Dexamethasone—atopic dermatitis	5.1e-05	0.00121	CcSEcCtD
Olopatadine—Dry skin—Betamethasone—atopic dermatitis	5.1e-05	0.00121	CcSEcCtD
Olopatadine—Infection—Tacrolimus—atopic dermatitis	5.1e-05	0.00121	CcSEcCtD
Olopatadine—Abdominal pain—Mometasone—atopic dermatitis	5.1e-05	0.00121	CcSEcCtD
Olopatadine—Body temperature increased—Mometasone—atopic dermatitis	5.1e-05	0.00121	CcSEcCtD
Olopatadine—Nervous system disorder—Tacrolimus—atopic dermatitis	5.03e-05	0.0012	CcSEcCtD
Olopatadine—Infestation NOS—Hydrocortisone—atopic dermatitis	5.02e-05	0.00119	CcSEcCtD
Olopatadine—Infestation—Hydrocortisone—atopic dermatitis	5.02e-05	0.00119	CcSEcCtD
Olopatadine—Conjunctivitis—Prednisolone—atopic dermatitis	5e-05	0.00119	CcSEcCtD
Olopatadine—Skin disorder—Tacrolimus—atopic dermatitis	4.99e-05	0.00118	CcSEcCtD
Olopatadine—Hypersensitivity—Fluocinolone Acetonide—atopic dermatitis	4.98e-05	0.00118	CcSEcCtD
Olopatadine—Dizziness—Loratadine—atopic dermatitis	4.97e-05	0.00118	CcSEcCtD
Olopatadine—S100B—TRAF6 Mediated Induction of proinflammatory cytokines—IL6—atopic dermatitis	4.94e-05	0.00339	CbGpPWpGaD
Olopatadine—S100A12—Toll-Like Receptors Cascades—MAPK8—atopic dermatitis	4.94e-05	0.00338	CbGpPWpGaD
Olopatadine—Upper respiratory tract infection—Triamcinolone—atopic dermatitis	4.93e-05	0.00117	CcSEcCtD
Olopatadine—Weight increased—Triamcinolone—atopic dermatitis	4.82e-05	0.00115	CcSEcCtD
Olopatadine—Weight increased—Methylprednisolone—atopic dermatitis	4.81e-05	0.00114	CcSEcCtD
Olopatadine—S100A12—Innate Immune System—CASP1—atopic dermatitis	4.8e-05	0.00329	CbGpPWpGaD
Olopatadine—Pruritus—Fluocinolone Acetonide—atopic dermatitis	4.78e-05	0.00113	CcSEcCtD
Olopatadine—Vomiting—Loratadine—atopic dermatitis	4.78e-05	0.00113	CcSEcCtD
Olopatadine—Rash—Loratadine—atopic dermatitis	4.74e-05	0.00113	CcSEcCtD
Olopatadine—Dermatitis—Loratadine—atopic dermatitis	4.73e-05	0.00112	CcSEcCtD
Olopatadine—S100A12—MyD88 cascade initiated on plasma membrane—IL6—atopic dermatitis	4.73e-05	0.00324	CbGpPWpGaD
Olopatadine—Infestation NOS—Methylprednisolone—atopic dermatitis	4.72e-05	0.00112	CcSEcCtD
Olopatadine—Infestation—Methylprednisolone—atopic dermatitis	4.72e-05	0.00112	CcSEcCtD
Olopatadine—Headache—Loratadine—atopic dermatitis	4.71e-05	0.00112	CcSEcCtD
Olopatadine—S100A12—TRAF6 mediated induction of NFkB and MAP kinases upon TLR7/8 or 9 activation—IL6—atopic dermatitis	4.68e-05	0.00321	CbGpPWpGaD
Olopatadine—S100B—Toll-Like Receptors Cascades—MAPK8—atopic dermatitis	4.67e-05	0.0032	CbGpPWpGaD
Olopatadine—Asthenia—Mometasone—atopic dermatitis	4.63e-05	0.0011	CcSEcCtD
Olopatadine—Diarrhoea—Fluocinolone Acetonide—atopic dermatitis	4.62e-05	0.0011	CcSEcCtD
Olopatadine—S100A12—MyD88 dependent cascade initiated on endosome—IL6—atopic dermatitis	4.6e-05	0.00315	CbGpPWpGaD
Olopatadine—Conjunctivitis—Triamcinolone—atopic dermatitis	4.59e-05	0.00109	CcSEcCtD
Olopatadine—Dyspnoea—Tacrolimus—atopic dermatitis	4.58e-05	0.00109	CcSEcCtD
Olopatadine—Somnolence—Tacrolimus—atopic dermatitis	4.56e-05	0.00108	CcSEcCtD
Olopatadine—Pruritus—Mometasone—atopic dermatitis	4.56e-05	0.00108	CcSEcCtD
Olopatadine—S100B—Innate Immune System—CASP1—atopic dermatitis	4.54e-05	0.00311	CbGpPWpGaD
Olopatadine—HRH1—Class A/1 (Rhodopsin-like receptors)—CCL22—atopic dermatitis	4.5e-05	0.00309	CbGpPWpGaD
Olopatadine—HRH1—IL-4 Signaling Pathway—NFKBIA—atopic dermatitis	4.48e-05	0.00307	CbGpPWpGaD
Olopatadine—S100B—MyD88 cascade initiated on plasma membrane—IL6—atopic dermatitis	4.47e-05	0.00306	CbGpPWpGaD
Olopatadine—Dizziness—Fluocinolone Acetonide—atopic dermatitis	4.47e-05	0.00106	CcSEcCtD
Olopatadine—Nausea—Loratadine—atopic dermatitis	4.46e-05	0.00106	CcSEcCtD
Olopatadine—Epistaxis—Triamcinolone—atopic dermatitis	4.46e-05	0.00106	CcSEcCtD
Olopatadine—Visual impairment—Prednisolone—atopic dermatitis	4.45e-05	0.00106	CcSEcCtD
Olopatadine—Dry skin—Prednisone—atopic dermatitis	4.44e-05	0.00106	CcSEcCtD
Olopatadine—S100A12—Toll Like Receptor 9 (TLR9) Cascade—IL6—atopic dermatitis	4.44e-05	0.00304	CbGpPWpGaD
Olopatadine—Gastrointestinal disorder—Tacrolimus—atopic dermatitis	4.43e-05	0.00105	CcSEcCtD
Olopatadine—S100B—TRAF6 mediated induction of NFkB and MAP kinases upon TLR7/8 or 9 activation—IL6—atopic dermatitis	4.43e-05	0.00304	CbGpPWpGaD
Olopatadine—Fatigue—Tacrolimus—atopic dermatitis	4.43e-05	0.00105	CcSEcCtD
Olopatadine—Diarrhoea—Mometasone—atopic dermatitis	4.41e-05	0.00105	CcSEcCtD
Olopatadine—Pain—Tacrolimus—atopic dermatitis	4.39e-05	0.00104	CcSEcCtD
Olopatadine—Weight increased—Dexamethasone—atopic dermatitis	4.38e-05	0.00104	CcSEcCtD
Olopatadine—Weight increased—Betamethasone—atopic dermatitis	4.38e-05	0.00104	CcSEcCtD
Olopatadine—S100A12—MyD88:Mal cascade initiated on plasma membrane—IL6—atopic dermatitis	4.36e-05	0.00299	CbGpPWpGaD
Olopatadine—S100B—MyD88 dependent cascade initiated on endosome—IL6—atopic dermatitis	4.35e-05	0.00298	CbGpPWpGaD
Olopatadine—S100A12—Innate Immune System—TLR2—atopic dermatitis	4.34e-05	0.00297	CbGpPWpGaD
Olopatadine—S100A12—Immune System—KIF3A—atopic dermatitis	4.34e-05	0.00297	CbGpPWpGaD
Olopatadine—Vomiting—Fluocinolone Acetonide—atopic dermatitis	4.29e-05	0.00102	CcSEcCtD
Olopatadine—Rash—Fluocinolone Acetonide—atopic dermatitis	4.26e-05	0.00101	CcSEcCtD
Olopatadine—Dermatitis—Fluocinolone Acetonide—atopic dermatitis	4.25e-05	0.00101	CcSEcCtD
Olopatadine—Rhinitis—Triamcinolone—atopic dermatitis	4.25e-05	0.00101	CcSEcCtD
Olopatadine—Rhinitis—Methylprednisolone—atopic dermatitis	4.24e-05	0.00101	CcSEcCtD
Olopatadine—Headache—Fluocinolone Acetonide—atopic dermatitis	4.23e-05	0.001	CcSEcCtD
Olopatadine—Feeling abnormal—Tacrolimus—atopic dermatitis	4.23e-05	0.001	CcSEcCtD
Olopatadine—Pharyngitis—Triamcinolone—atopic dermatitis	4.21e-05	0.001	CcSEcCtD
Olopatadine—Eye disorder—Hydrocortisone—atopic dermatitis	4.21e-05	0.001	CcSEcCtD
Olopatadine—Gastrointestinal pain—Tacrolimus—atopic dermatitis	4.2e-05	0.000997	CcSEcCtD
Olopatadine—S100B—Toll Like Receptor 9 (TLR9) Cascade—IL6—atopic dermatitis	4.2e-05	0.00288	CbGpPWpGaD
Olopatadine—S100A12—MyD88-independent cascade—IL6—atopic dermatitis	4.19e-05	0.00287	CbGpPWpGaD
Olopatadine—Conjunctivitis—Dexamethasone—atopic dermatitis	4.17e-05	0.00099	CcSEcCtD
Olopatadine—Conjunctivitis—Betamethasone—atopic dermatitis	4.17e-05	0.00099	CcSEcCtD
Olopatadine—S100B—MyD88:Mal cascade initiated on plasma membrane—IL6—atopic dermatitis	4.13e-05	0.00283	CbGpPWpGaD
Olopatadine—S100B—Innate Immune System—TLR2—atopic dermatitis	4.1e-05	0.00281	CbGpPWpGaD
Olopatadine—S100B—Immune System—KIF3A—atopic dermatitis	4.1e-05	0.00281	CbGpPWpGaD
Olopatadine—Vomiting—Mometasone—atopic dermatitis	4.1e-05	0.000974	CcSEcCtD
Olopatadine—Visual impairment—Methylprednisolone—atopic dermatitis	4.08e-05	0.000969	CcSEcCtD
Olopatadine—Immune system disorder—Hydrocortisone—atopic dermatitis	4.07e-05	0.000967	CcSEcCtD
Olopatadine—Rash—Mometasone—atopic dermatitis	4.07e-05	0.000966	CcSEcCtD
Olopatadine—Dermatitis—Mometasone—atopic dermatitis	4.06e-05	0.000965	CcSEcCtD
Olopatadine—Body temperature increased—Tacrolimus—atopic dermatitis	4.06e-05	0.000964	CcSEcCtD
Olopatadine—Abdominal pain—Tacrolimus—atopic dermatitis	4.06e-05	0.000964	CcSEcCtD
Olopatadine—Headache—Mometasone—atopic dermatitis	4.04e-05	0.00096	CcSEcCtD
Olopatadine—Erythema—Prednisolone—atopic dermatitis	4.02e-05	0.000954	CcSEcCtD
Olopatadine—HRH1—Class A/1 (Rhodopsin-like receptors)—CCL27—atopic dermatitis	4.01e-05	0.00275	CbGpPWpGaD
Olopatadine—Nausea—Fluocinolone Acetonide—atopic dermatitis	4.01e-05	0.000953	CcSEcCtD
Olopatadine—S100B—Signaling Pathways—FCER2—atopic dermatitis	4e-05	0.00274	CbGpPWpGaD
Olopatadine—S100B—MyD88-independent cascade—IL6—atopic dermatitis	3.96e-05	0.00271	CbGpPWpGaD
Olopatadine—Eye disorder—Methylprednisolone—atopic dermatitis	3.96e-05	0.00094	CcSEcCtD
Olopatadine—Erythema—Hydrocortisone—atopic dermatitis	3.92e-05	0.000932	CcSEcCtD
Olopatadine—Nausea—Mometasone—atopic dermatitis	3.83e-05	0.00091	CcSEcCtD
Olopatadine—Immune system disorder—Methylprednisolone—atopic dermatitis	3.82e-05	0.000908	CcSEcCtD
Olopatadine—Mediastinal disorder—Methylprednisolone—atopic dermatitis	3.82e-05	0.000906	CcSEcCtD
Olopatadine—Weight increased—Prednisone—atopic dermatitis	3.81e-05	0.000906	CcSEcCtD
Olopatadine—Vision blurred—Prednisolone—atopic dermatitis	3.79e-05	0.000899	CcSEcCtD
Olopatadine—Hypersensitivity—Tacrolimus—atopic dermatitis	3.78e-05	0.000898	CcSEcCtD
Olopatadine—S100A12—Activated TLR4 signalling—IL6—atopic dermatitis	3.77e-05	0.00258	CbGpPWpGaD
Olopatadine—Ill-defined disorder—Prednisolone—atopic dermatitis	3.73e-05	0.000885	CcSEcCtD
Olopatadine—Depression—Prednisone—atopic dermatitis	3.72e-05	0.000885	CcSEcCtD
Olopatadine—S100B—Signaling Pathways—CCL22—atopic dermatitis	3.72e-05	0.00255	CbGpPWpGaD
Olopatadine—Visual impairment—Dexamethasone—atopic dermatitis	3.71e-05	0.000881	CcSEcCtD
Olopatadine—Visual impairment—Betamethasone—atopic dermatitis	3.71e-05	0.000881	CcSEcCtD
Olopatadine—Erythema—Triamcinolone—atopic dermatitis	3.69e-05	0.000877	CcSEcCtD
Olopatadine—S100A12—Immune System—STAT6—atopic dermatitis	3.69e-05	0.00253	CbGpPWpGaD
Olopatadine—Erythema—Methylprednisolone—atopic dermatitis	3.69e-05	0.000875	CcSEcCtD
Olopatadine—Asthenia—Tacrolimus—atopic dermatitis	3.68e-05	0.000875	CcSEcCtD
Olopatadine—Ill-defined disorder—Hydrocortisone—atopic dermatitis	3.64e-05	0.000865	CcSEcCtD
Olopatadine—Pruritus—Tacrolimus—atopic dermatitis	3.63e-05	0.000862	CcSEcCtD
Olopatadine—Malaise—Prednisolone—atopic dermatitis	3.62e-05	0.00086	CcSEcCtD
Olopatadine—Dysgeusia—Triamcinolone—atopic dermatitis	3.62e-05	0.000859	CcSEcCtD
Olopatadine—HRH1—Class A/1 (Rhodopsin-like receptors)—CCL17—atopic dermatitis	3.6e-05	0.00247	CbGpPWpGaD
Olopatadine—Eye disorder—Betamethasone—atopic dermatitis	3.6e-05	0.000855	CcSEcCtD
Olopatadine—Eye disorder—Dexamethasone—atopic dermatitis	3.6e-05	0.000855	CcSEcCtD
Olopatadine—S100A12—Immune System—CARD11—atopic dermatitis	3.59e-05	0.00246	CbGpPWpGaD
Olopatadine—Back pain—Triamcinolone—atopic dermatitis	3.57e-05	0.000849	CcSEcCtD
Olopatadine—S100B—Activated TLR4 signalling—IL6—atopic dermatitis	3.56e-05	0.00244	CbGpPWpGaD
Olopatadine—S100A12—Toll Like Receptor 4 (TLR4) Cascade—IL6—atopic dermatitis	3.54e-05	0.00243	CbGpPWpGaD
Olopatadine—Malaise—Hydrocortisone—atopic dermatitis	3.54e-05	0.00084	CcSEcCtD
Olopatadine—Diarrhoea—Tacrolimus—atopic dermatitis	3.51e-05	0.000834	CcSEcCtD
Olopatadine—S100B—Immune System—STAT6—atopic dermatitis	3.49e-05	0.00239	CbGpPWpGaD
Olopatadine—HRH1—GPCR ligand binding—CCL22—atopic dermatitis	3.43e-05	0.00235	CbGpPWpGaD
Olopatadine—Ill-defined disorder—Triamcinolone—atopic dermatitis	3.43e-05	0.000814	CcSEcCtD
Olopatadine—Ill-defined disorder—Methylprednisolone—atopic dermatitis	3.42e-05	0.000812	CcSEcCtD
Olopatadine—Dizziness—Tacrolimus—atopic dermatitis	3.39e-05	0.000806	CcSEcCtD
Olopatadine—S100B—Immune System—CARD11—atopic dermatitis	3.39e-05	0.00233	CbGpPWpGaD
Olopatadine—Discomfort—Prednisolone—atopic dermatitis	3.38e-05	0.000803	CcSEcCtD
Olopatadine—Erythema—Dexamethasone—atopic dermatitis	3.35e-05	0.000796	CcSEcCtD
Olopatadine—Erythema—Betamethasone—atopic dermatitis	3.35e-05	0.000796	CcSEcCtD
Olopatadine—S100B—Toll Like Receptor 4 (TLR4) Cascade—IL6—atopic dermatitis	3.35e-05	0.00229	CbGpPWpGaD
Olopatadine—Malaise—Triamcinolone—atopic dermatitis	3.33e-05	0.000791	CcSEcCtD
Olopatadine—Malaise—Methylprednisolone—atopic dermatitis	3.32e-05	0.000789	CcSEcCtD
Olopatadine—S100B—Signaling Pathways—CCL27—atopic dermatitis	3.32e-05	0.00227	CbGpPWpGaD
Olopatadine—Unspecified disorder of skin and subcutaneous tissue—Hydrocortisone—atopic dermatitis	3.32e-05	0.000788	CcSEcCtD
Olopatadine—Discomfort—Hydrocortisone—atopic dermatitis	3.3e-05	0.000784	CcSEcCtD
Olopatadine—Oedema—Prednisolone—atopic dermatitis	3.28e-05	0.000779	CcSEcCtD
Olopatadine—Vomiting—Tacrolimus—atopic dermatitis	3.26e-05	0.000775	CcSEcCtD
Olopatadine—Rash—Tacrolimus—atopic dermatitis	3.24e-05	0.000769	CcSEcCtD
Olopatadine—Dermatitis—Tacrolimus—atopic dermatitis	3.23e-05	0.000768	CcSEcCtD
Olopatadine—Cough—Triamcinolone—atopic dermatitis	3.22e-05	0.000766	CcSEcCtD
Olopatadine—Headache—Tacrolimus—atopic dermatitis	3.22e-05	0.000764	CcSEcCtD
Olopatadine—Oedema—Hydrocortisone—atopic dermatitis	3.2e-05	0.00076	CcSEcCtD
Olopatadine—HRH1—G alpha (q) signalling events—NPS—atopic dermatitis	3.18e-05	0.00218	CbGpPWpGaD
Olopatadine—HRH1—G alpha (q) signalling events—TAC1—atopic dermatitis	3.18e-05	0.00218	CbGpPWpGaD
Olopatadine—Infection—Hydrocortisone—atopic dermatitis	3.18e-05	0.000755	CcSEcCtD
Olopatadine—S100A12—Toll-Like Receptors Cascades—IL6—atopic dermatitis	3.15e-05	0.00216	CbGpPWpGaD
Olopatadine—Nervous system disorder—Hydrocortisone—atopic dermatitis	3.14e-05	0.000746	CcSEcCtD
Olopatadine—Eye disorder—Prednisone—atopic dermatitis	3.13e-05	0.000744	CcSEcCtD
Olopatadine—Unspecified disorder of skin and subcutaneous tissue—Methylprednisolone—atopic dermatitis	3.12e-05	0.00074	CcSEcCtD
Olopatadine—Skin disorder—Hydrocortisone—atopic dermatitis	3.11e-05	0.000739	CcSEcCtD
Olopatadine—Ill-defined disorder—Betamethasone—atopic dermatitis	3.11e-05	0.000739	CcSEcCtD
Olopatadine—Ill-defined disorder—Dexamethasone—atopic dermatitis	3.11e-05	0.000739	CcSEcCtD
Olopatadine—Discomfort—Triamcinolone—atopic dermatitis	3.11e-05	0.000738	CcSEcCtD
Olopatadine—Discomfort—Methylprednisolone—atopic dermatitis	3.1e-05	0.000736	CcSEcCtD
Olopatadine—Dry mouth—Triamcinolone—atopic dermatitis	3.08e-05	0.000731	CcSEcCtD
Olopatadine—HRH1—GPCR ligand binding—CCL27—atopic dermatitis	3.06e-05	0.00209	CbGpPWpGaD
Olopatadine—Nausea—Tacrolimus—atopic dermatitis	3.05e-05	0.000724	CcSEcCtD
Olopatadine—Immune system disorder—Prednisone—atopic dermatitis	3.03e-05	0.000719	CcSEcCtD
Olopatadine—Malaise—Dexamethasone—atopic dermatitis	3.02e-05	0.000718	CcSEcCtD
Olopatadine—Malaise—Betamethasone—atopic dermatitis	3.02e-05	0.000718	CcSEcCtD
Olopatadine—Oedema—Triamcinolone—atopic dermatitis	3.01e-05	0.000716	CcSEcCtD
Olopatadine—Infection—Triamcinolone—atopic dermatitis	3e-05	0.000711	CcSEcCtD
Olopatadine—Infection—Methylprednisolone—atopic dermatitis	2.99e-05	0.00071	CcSEcCtD
Olopatadine—S100B—Toll-Like Receptors Cascades—IL6—atopic dermatitis	2.98e-05	0.00204	CbGpPWpGaD
Olopatadine—S100B—Signaling Pathways—CCL17—atopic dermatitis	2.98e-05	0.00204	CbGpPWpGaD
Olopatadine—Nervous system disorder—Methylprednisolone—atopic dermatitis	2.95e-05	0.000701	CcSEcCtD
Olopatadine—Skin disorder—Methylprednisolone—atopic dermatitis	2.92e-05	0.000694	CcSEcCtD
Olopatadine—Erythema—Prednisone—atopic dermatitis	2.92e-05	0.000693	CcSEcCtD
Olopatadine—HRH1—Class A/1 (Rhodopsin-like receptors)—CCL11—atopic dermatitis	2.9e-05	0.00199	CbGpPWpGaD
Olopatadine—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARA—atopic dermatitis	2.85e-05	0.00195	CbGpPWpGaD
Olopatadine—HRH1—Gastrin-CREB signalling pathway via PKC and MAPK—TAC1—atopic dermatitis	2.85e-05	0.00195	CbGpPWpGaD
Olopatadine—HRH1—Gastrin-CREB signalling pathway via PKC and MAPK—NPS—atopic dermatitis	2.85e-05	0.00195	CbGpPWpGaD
Olopatadine—Discomfort—Dexamethasone—atopic dermatitis	2.82e-05	0.00067	CcSEcCtD
Olopatadine—Discomfort—Betamethasone—atopic dermatitis	2.82e-05	0.00067	CcSEcCtD
Olopatadine—S100B—Signaling by ERBB4—IL6—atopic dermatitis	2.81e-05	0.00192	CbGpPWpGaD
Olopatadine—Pain—Prednisolone—atopic dermatitis	2.8e-05	0.000666	CcSEcCtD
Olopatadine—S100A12—Immune System—CASP1—atopic dermatitis	2.8e-05	0.00192	CbGpPWpGaD
Olopatadine—Gastrointestinal disorder—Hydrocortisone—atopic dermatitis	2.76e-05	0.000657	CcSEcCtD
Olopatadine—HRH1—GPCRs, Class A Rhodopsin-like—CCR3—atopic dermatitis	2.76e-05	0.00189	CbGpPWpGaD
Olopatadine—Fatigue—Hydrocortisone—atopic dermatitis	2.76e-05	0.000656	CcSEcCtD
Olopatadine—Vision blurred—Prednisone—atopic dermatitis	2.75e-05	0.000653	CcSEcCtD
Olopatadine—HRH1—GPCR ligand binding—CCL17—atopic dermatitis	2.74e-05	0.00188	CbGpPWpGaD
Olopatadine—Pain—Hydrocortisone—atopic dermatitis	2.74e-05	0.00065	CcSEcCtD
Olopatadine—Oedema—Betamethasone—atopic dermatitis	2.74e-05	0.00065	CcSEcCtD
Olopatadine—Oedema—Dexamethasone—atopic dermatitis	2.74e-05	0.00065	CcSEcCtD
Olopatadine—Infection—Dexamethasone—atopic dermatitis	2.72e-05	0.000645	CcSEcCtD
Olopatadine—Infection—Betamethasone—atopic dermatitis	2.72e-05	0.000645	CcSEcCtD
Olopatadine—Ill-defined disorder—Prednisone—atopic dermatitis	2.71e-05	0.000643	CcSEcCtD
Olopatadine—Feeling abnormal—Prednisolone—atopic dermatitis	2.7e-05	0.000642	CcSEcCtD
Olopatadine—Dyspnoea—Triamcinolone—atopic dermatitis	2.69e-05	0.000638	CcSEcCtD
Olopatadine—Nervous system disorder—Dexamethasone—atopic dermatitis	2.68e-05	0.000637	CcSEcCtD
Olopatadine—Nervous system disorder—Betamethasone—atopic dermatitis	2.68e-05	0.000637	CcSEcCtD
Olopatadine—S100B—Signaling Pathways—KIF3A—atopic dermatitis	2.65e-05	0.00182	CbGpPWpGaD
Olopatadine—S100A12—Immune System—IL5—atopic dermatitis	2.65e-05	0.00182	CbGpPWpGaD
Olopatadine—S100B—Immune System—CASP1—atopic dermatitis	2.64e-05	0.00181	CbGpPWpGaD
Olopatadine—Feeling abnormal—Hydrocortisone—atopic dermatitis	2.64e-05	0.000627	CcSEcCtD
Olopatadine—Malaise—Prednisone—atopic dermatitis	2.63e-05	0.000625	CcSEcCtD
Olopatadine—Gastrointestinal pain—Hydrocortisone—atopic dermatitis	2.62e-05	0.000622	CcSEcCtD
Olopatadine—Fatigue—Triamcinolone—atopic dermatitis	2.6e-05	0.000617	CcSEcCtD
Olopatadine—Fatigue—Methylprednisolone—atopic dermatitis	2.59e-05	0.000616	CcSEcCtD
Olopatadine—Pain—Triamcinolone—atopic dermatitis	2.58e-05	0.000612	CcSEcCtD
Olopatadine—S100A12—Innate Immune System—NFKBIA—atopic dermatitis	2.55e-05	0.00175	CbGpPWpGaD
Olopatadine—Body temperature increased—Hydrocortisone—atopic dermatitis	2.53e-05	0.000601	CcSEcCtD
Olopatadine—Abdominal pain—Hydrocortisone—atopic dermatitis	2.53e-05	0.000601	CcSEcCtD
Olopatadine—S100A12—Immune System—TLR2—atopic dermatitis	2.53e-05	0.00173	CbGpPWpGaD
Olopatadine—S100B—Immune System—IL5—atopic dermatitis	2.51e-05	0.00172	CbGpPWpGaD
Olopatadine—Feeling abnormal—Triamcinolone—atopic dermatitis	2.48e-05	0.00059	CcSEcCtD
Olopatadine—Feeling abnormal—Methylprednisolone—atopic dermatitis	2.48e-05	0.000589	CcSEcCtD
Olopatadine—Unspecified disorder of skin and subcutaneous tissue—Prednisone—atopic dermatitis	2.47e-05	0.000586	CcSEcCtD
Olopatadine—Gastrointestinal pain—Methylprednisolone—atopic dermatitis	2.46e-05	0.000584	CcSEcCtD
Olopatadine—Discomfort—Prednisone—atopic dermatitis	2.46e-05	0.000583	CcSEcCtD
Olopatadine—Hypersensitivity—Prednisolone—atopic dermatitis	2.42e-05	0.000574	CcSEcCtD
Olopatadine—HRH1—GPCRs, Class A Rhodopsin-like—CXCR3—atopic dermatitis	2.41e-05	0.00165	CbGpPWpGaD
Olopatadine—S100B—Innate Immune System—NFKBIA—atopic dermatitis	2.41e-05	0.00165	CbGpPWpGaD
Olopatadine—S100B—Signaling Pathways—CCL11—atopic dermatitis	2.4e-05	0.00164	CbGpPWpGaD
Olopatadine—S100B—Signaling Pathways—CMA1—atopic dermatitis	2.4e-05	0.00164	CbGpPWpGaD
Olopatadine—S100B—Immune System—TLR2—atopic dermatitis	2.39e-05	0.00164	CbGpPWpGaD
Olopatadine—Body temperature increased—Triamcinolone—atopic dermatitis	2.38e-05	0.000566	CcSEcCtD
Olopatadine—Oedema—Prednisone—atopic dermatitis	2.38e-05	0.000566	CcSEcCtD
Olopatadine—Abdominal pain—Methylprednisolone—atopic dermatitis	2.38e-05	0.000565	CcSEcCtD
Olopatadine—S100A12—Immune System—CD79A—atopic dermatitis	2.38e-05	0.00163	CbGpPWpGaD
Olopatadine—Infection—Prednisone—atopic dermatitis	2.37e-05	0.000562	CcSEcCtD
Olopatadine—HRH1—Class A/1 (Rhodopsin-like receptors)—CCR3—atopic dermatitis	2.37e-05	0.00162	CbGpPWpGaD
Olopatadine—Gastrointestinal disorder—Dexamethasone—atopic dermatitis	2.36e-05	0.000561	CcSEcCtD
Olopatadine—Gastrointestinal disorder—Betamethasone—atopic dermatitis	2.36e-05	0.000561	CcSEcCtD
Olopatadine—Hypersensitivity—Hydrocortisone—atopic dermatitis	2.36e-05	0.00056	CcSEcCtD
Olopatadine—Fatigue—Dexamethasone—atopic dermatitis	2.36e-05	0.00056	CcSEcCtD
Olopatadine—Fatigue—Betamethasone—atopic dermatitis	2.36e-05	0.00056	CcSEcCtD
Olopatadine—Pain—Dexamethasone—atopic dermatitis	2.34e-05	0.000556	CcSEcCtD
Olopatadine—Pain—Betamethasone—atopic dermatitis	2.34e-05	0.000556	CcSEcCtD
Olopatadine—Nervous system disorder—Prednisone—atopic dermatitis	2.34e-05	0.000555	CcSEcCtD
Olopatadine—Skin disorder—Prednisone—atopic dermatitis	2.31e-05	0.00055	CcSEcCtD
Olopatadine—S100A12—Innate Immune System—CASP8—atopic dermatitis	2.3e-05	0.00158	CbGpPWpGaD
Olopatadine—Asthenia—Hydrocortisone—atopic dermatitis	2.3e-05	0.000546	CcSEcCtD
Olopatadine—Pruritus—Hydrocortisone—atopic dermatitis	2.27e-05	0.000538	CcSEcCtD
Olopatadine—S100B—Signaling Pathways—STAT6—atopic dermatitis	2.25e-05	0.00155	CbGpPWpGaD
Olopatadine—Feeling abnormal—Betamethasone—atopic dermatitis	2.25e-05	0.000535	CcSEcCtD
Olopatadine—Feeling abnormal—Dexamethasone—atopic dermatitis	2.25e-05	0.000535	CcSEcCtD
Olopatadine—S100B—Immune System—CD79A—atopic dermatitis	2.25e-05	0.00154	CbGpPWpGaD
Olopatadine—Gastrointestinal pain—Betamethasone—atopic dermatitis	2.24e-05	0.000531	CcSEcCtD
Olopatadine—Gastrointestinal pain—Dexamethasone—atopic dermatitis	2.24e-05	0.000531	CcSEcCtD
Olopatadine—Hypersensitivity—Triamcinolone—atopic dermatitis	2.22e-05	0.000528	CcSEcCtD
Olopatadine—Hypersensitivity—Methylprednisolone—atopic dermatitis	2.22e-05	0.000526	CcSEcCtD
Olopatadine—HRH1—GPCR ligand binding—CCL11—atopic dermatitis	2.21e-05	0.00151	CbGpPWpGaD
Olopatadine—Diarrhoea—Hydrocortisone—atopic dermatitis	2.19e-05	0.00052	CcSEcCtD
Olopatadine—S100B—Innate Immune System—CASP8—atopic dermatitis	2.18e-05	0.00149	CbGpPWpGaD
Olopatadine—Dizziness—Prednisolone—atopic dermatitis	2.17e-05	0.000515	CcSEcCtD
Olopatadine—Asthenia—Triamcinolone—atopic dermatitis	2.16e-05	0.000514	CcSEcCtD
Olopatadine—Body temperature increased—Betamethasone—atopic dermatitis	2.16e-05	0.000514	CcSEcCtD
Olopatadine—Body temperature increased—Dexamethasone—atopic dermatitis	2.16e-05	0.000514	CcSEcCtD
Olopatadine—Abdominal pain—Dexamethasone—atopic dermatitis	2.16e-05	0.000514	CcSEcCtD
Olopatadine—Abdominal pain—Betamethasone—atopic dermatitis	2.16e-05	0.000514	CcSEcCtD
Olopatadine—Asthenia—Methylprednisolone—atopic dermatitis	2.16e-05	0.000513	CcSEcCtD
Olopatadine—Pruritus—Triamcinolone—atopic dermatitis	2.13e-05	0.000507	CcSEcCtD
Olopatadine—Pruritus—Methylprednisolone—atopic dermatitis	2.13e-05	0.000505	CcSEcCtD
Olopatadine—Dizziness—Hydrocortisone—atopic dermatitis	2.12e-05	0.000503	CcSEcCtD
Olopatadine—HRH1—Class A/1 (Rhodopsin-like receptors)—NPS—atopic dermatitis	2.11e-05	0.00144	CbGpPWpGaD
Olopatadine—HRH1—Class A/1 (Rhodopsin-like receptors)—TAC1—atopic dermatitis	2.11e-05	0.00144	CbGpPWpGaD
Olopatadine—HRH1—Class A/1 (Rhodopsin-like receptors)—CXCR3—atopic dermatitis	2.07e-05	0.00142	CbGpPWpGaD
Olopatadine—Rash—Prednisolone—atopic dermatitis	2.07e-05	0.000491	CcSEcCtD
Olopatadine—Dermatitis—Prednisolone—atopic dermatitis	2.07e-05	0.00049	CcSEcCtD
Olopatadine—Diarrhoea—Methylprednisolone—atopic dermatitis	2.06e-05	0.000489	CcSEcCtD
Olopatadine—Fatigue—Prednisone—atopic dermatitis	2.05e-05	0.000488	CcSEcCtD
Olopatadine—Headache—Prednisolone—atopic dermatitis	2.05e-05	0.000488	CcSEcCtD
Olopatadine—Vomiting—Hydrocortisone—atopic dermatitis	2.04e-05	0.000484	CcSEcCtD
Olopatadine—Rash—Hydrocortisone—atopic dermatitis	2.02e-05	0.000479	CcSEcCtD
Olopatadine—Dermatitis—Hydrocortisone—atopic dermatitis	2.02e-05	0.000479	CcSEcCtD
Olopatadine—Headache—Hydrocortisone—atopic dermatitis	2.01e-05	0.000476	CcSEcCtD
Olopatadine—Dizziness—Triamcinolone—atopic dermatitis	1.99e-05	0.000474	CcSEcCtD
Olopatadine—Dizziness—Methylprednisolone—atopic dermatitis	1.99e-05	0.000472	CcSEcCtD
Olopatadine—Feeling abnormal—Prednisone—atopic dermatitis	1.96e-05	0.000466	CcSEcCtD
Olopatadine—Asthenia—Betamethasone—atopic dermatitis	1.96e-05	0.000466	CcSEcCtD
Olopatadine—Asthenia—Dexamethasone—atopic dermatitis	1.96e-05	0.000466	CcSEcCtD
Olopatadine—S100B—Signaling Pathways—CCR3—atopic dermatitis	1.96e-05	0.00134	CbGpPWpGaD
Olopatadine—Gastrointestinal pain—Prednisone—atopic dermatitis	1.95e-05	0.000463	CcSEcCtD
Olopatadine—Nausea—Prednisolone—atopic dermatitis	1.95e-05	0.000463	CcSEcCtD
Olopatadine—S100A12—Immune System—IL18—atopic dermatitis	1.94e-05	0.00133	CbGpPWpGaD
Olopatadine—Pruritus—Dexamethasone—atopic dermatitis	1.94e-05	0.00046	CcSEcCtD
Olopatadine—Pruritus—Betamethasone—atopic dermatitis	1.94e-05	0.00046	CcSEcCtD
Olopatadine—Vomiting—Triamcinolone—atopic dermatitis	1.92e-05	0.000455	CcSEcCtD
Olopatadine—S100A12—Immune System—CD8A—atopic dermatitis	1.92e-05	0.00131	CbGpPWpGaD
Olopatadine—Vomiting—Methylprednisolone—atopic dermatitis	1.91e-05	0.000454	CcSEcCtD
Olopatadine—Nausea—Hydrocortisone—atopic dermatitis	1.9e-05	0.000452	CcSEcCtD
Olopatadine—Rash—Triamcinolone—atopic dermatitis	1.9e-05	0.000451	CcSEcCtD
Olopatadine—Dermatitis—Triamcinolone—atopic dermatitis	1.9e-05	0.000451	CcSEcCtD
Olopatadine—Rash—Methylprednisolone—atopic dermatitis	1.9e-05	0.00045	CcSEcCtD
Olopatadine—Dermatitis—Methylprednisolone—atopic dermatitis	1.89e-05	0.00045	CcSEcCtD
Olopatadine—S100A12—Innate Immune System—CD4—atopic dermatitis	1.89e-05	0.00129	CbGpPWpGaD
Olopatadine—Headache—Triamcinolone—atopic dermatitis	1.89e-05	0.000449	CcSEcCtD
Olopatadine—Headache—Methylprednisolone—atopic dermatitis	1.88e-05	0.000448	CcSEcCtD
Olopatadine—Body temperature increased—Prednisone—atopic dermatitis	1.88e-05	0.000447	CcSEcCtD
Olopatadine—Abdominal pain—Prednisone—atopic dermatitis	1.88e-05	0.000447	CcSEcCtD
Olopatadine—Diarrhoea—Betamethasone—atopic dermatitis	1.87e-05	0.000445	CcSEcCtD
Olopatadine—Diarrhoea—Dexamethasone—atopic dermatitis	1.87e-05	0.000445	CcSEcCtD
Olopatadine—S100B—Immune System—IL18—atopic dermatitis	1.84e-05	0.00126	CbGpPWpGaD
Olopatadine—S100B—Immune System—CD8A—atopic dermatitis	1.81e-05	0.00124	CbGpPWpGaD
Olopatadine—Dizziness—Dexamethasone—atopic dermatitis	1.81e-05	0.00043	CcSEcCtD
Olopatadine—Dizziness—Betamethasone—atopic dermatitis	1.81e-05	0.00043	CcSEcCtD
Olopatadine—HRH1—GPCR ligand binding—CCR3—atopic dermatitis	1.8e-05	0.00123	CbGpPWpGaD
Olopatadine—Nausea—Triamcinolone—atopic dermatitis	1.79e-05	0.000425	CcSEcCtD
Olopatadine—Nausea—Methylprednisolone—atopic dermatitis	1.79e-05	0.000424	CcSEcCtD
Olopatadine—S100B—Innate Immune System—CD4—atopic dermatitis	1.79e-05	0.00122	CbGpPWpGaD
Olopatadine—HRH1—Signaling by GPCR—CCL22—atopic dermatitis	1.76e-05	0.00121	CbGpPWpGaD
Olopatadine—Hypersensitivity—Prednisone—atopic dermatitis	1.76e-05	0.000417	CcSEcCtD
Olopatadine—S100B—Signaling Pathways—NPS—atopic dermatitis	1.74e-05	0.00119	CbGpPWpGaD
Olopatadine—S100B—Signaling Pathways—TAC1—atopic dermatitis	1.74e-05	0.00119	CbGpPWpGaD
Olopatadine—Vomiting—Betamethasone—atopic dermatitis	1.74e-05	0.000413	CcSEcCtD
Olopatadine—Vomiting—Dexamethasone—atopic dermatitis	1.74e-05	0.000413	CcSEcCtD
Olopatadine—HRH1—GPCR downstream signaling—CCL27—atopic dermatitis	1.73e-05	0.00118	CbGpPWpGaD
Olopatadine—Rash—Betamethasone—atopic dermatitis	1.72e-05	0.00041	CcSEcCtD
Olopatadine—Rash—Dexamethasone—atopic dermatitis	1.72e-05	0.00041	CcSEcCtD
Olopatadine—Dermatitis—Betamethasone—atopic dermatitis	1.72e-05	0.000409	CcSEcCtD
Olopatadine—Dermatitis—Dexamethasone—atopic dermatitis	1.72e-05	0.000409	CcSEcCtD
Olopatadine—Headache—Betamethasone—atopic dermatitis	1.71e-05	0.000407	CcSEcCtD
Olopatadine—Headache—Dexamethasone—atopic dermatitis	1.71e-05	0.000407	CcSEcCtD
Olopatadine—Asthenia—Prednisone—atopic dermatitis	1.71e-05	0.000406	CcSEcCtD
Olopatadine—S100B—Signaling Pathways—CXCR3—atopic dermatitis	1.71e-05	0.00117	CbGpPWpGaD
Olopatadine—Pruritus—Prednisone—atopic dermatitis	1.69e-05	0.0004	CcSEcCtD
Olopatadine—HRH1—Class A/1 (Rhodopsin-like receptors)—CXCL10—atopic dermatitis	1.67e-05	0.00115	CbGpPWpGaD
Olopatadine—Diarrhoea—Prednisone—atopic dermatitis	1.63e-05	0.000387	CcSEcCtD
Olopatadine—Nausea—Betamethasone—atopic dermatitis	1.62e-05	0.000386	CcSEcCtD
Olopatadine—Nausea—Dexamethasone—atopic dermatitis	1.62e-05	0.000386	CcSEcCtD
Olopatadine—S100B—Signaling Pathways—IL5—atopic dermatitis	1.62e-05	0.00111	CbGpPWpGaD
Olopatadine—HRH1—GPCR ligand binding—TAC1—atopic dermatitis	1.61e-05	0.0011	CbGpPWpGaD
Olopatadine—HRH1—GPCR ligand binding—NPS—atopic dermatitis	1.61e-05	0.0011	CbGpPWpGaD
Olopatadine—S100A12—Innate Immune System—MAPK8—atopic dermatitis	1.6e-05	0.0011	CbGpPWpGaD
Olopatadine—Dizziness—Prednisone—atopic dermatitis	1.58e-05	0.000374	CcSEcCtD
Olopatadine—HRH1—GPCR ligand binding—CXCR3—atopic dermatitis	1.57e-05	0.00108	CbGpPWpGaD
Olopatadine—HRH1—Signaling by GPCR—CCL27—atopic dermatitis	1.57e-05	0.00107	CbGpPWpGaD
Olopatadine—Vomiting—Prednisone—atopic dermatitis	1.51e-05	0.00036	CcSEcCtD
Olopatadine—S100B—Innate Immune System—MAPK8—atopic dermatitis	1.51e-05	0.00104	CbGpPWpGaD
Olopatadine—HRH1—GPCRs, Class A Rhodopsin-like—CCR5—atopic dermatitis	1.51e-05	0.00104	CbGpPWpGaD
Olopatadine—Rash—Prednisone—atopic dermatitis	1.5e-05	0.000357	CcSEcCtD
Olopatadine—Dermatitis—Prednisone—atopic dermatitis	1.5e-05	0.000356	CcSEcCtD
Olopatadine—Headache—Prednisone—atopic dermatitis	1.49e-05	0.000354	CcSEcCtD
Olopatadine—S100A12—Immune System—NFKBIA—atopic dermatitis	1.49e-05	0.00102	CbGpPWpGaD
Olopatadine—HRH1—Class A/1 (Rhodopsin-like receptors)—CCL5—atopic dermatitis	1.44e-05	0.000986	CbGpPWpGaD
Olopatadine—Nausea—Prednisone—atopic dermatitis	1.42e-05	0.000336	CcSEcCtD
Olopatadine—HRH1—Signaling by GPCR—CCL17—atopic dermatitis	1.41e-05	0.000964	CbGpPWpGaD
Olopatadine—S100B—Immune System—NFKBIA—atopic dermatitis	1.4e-05	0.000963	CbGpPWpGaD
Olopatadine—S100B—Signaling Pathways—CXCL10—atopic dermatitis	1.38e-05	0.000947	CbGpPWpGaD
Olopatadine—S100A12—Immune System—CASP8—atopic dermatitis	1.34e-05	0.000918	CbGpPWpGaD
Olopatadine—HRH1—Class A/1 (Rhodopsin-like receptors)—CCR5—atopic dermatitis	1.3e-05	0.000888	CbGpPWpGaD
Olopatadine—HRH1—GPCR ligand binding—CXCL10—atopic dermatitis	1.27e-05	0.000872	CbGpPWpGaD
Olopatadine—S100B—Immune System—CASP8—atopic dermatitis	1.27e-05	0.000868	CbGpPWpGaD
Olopatadine—S100B—Signaling Pathways—CCL5—atopic dermatitis	1.19e-05	0.000815	CbGpPWpGaD
Olopatadine—S100A12—Immune System—IFNG—atopic dermatitis	1.14e-05	0.000781	CbGpPWpGaD
Olopatadine—HRH1—Signaling by GPCR—CCL11—atopic dermatitis	1.13e-05	0.000777	CbGpPWpGaD
Olopatadine—HRH1—Signaling Pathways—FCER2—atopic dermatitis	1.12e-05	0.000766	CbGpPWpGaD
Olopatadine—S100B—Signaling Pathways—NGF—atopic dermatitis	1.1e-05	0.000755	CbGpPWpGaD
Olopatadine—S100A12—Immune System—CD4—atopic dermatitis	1.1e-05	0.000754	CbGpPWpGaD
Olopatadine—HRH1—GPCR ligand binding—CCL5—atopic dermatitis	1.1e-05	0.000751	CbGpPWpGaD
Olopatadine—S100B—Immune System—IFNG—atopic dermatitis	1.08e-05	0.000738	CbGpPWpGaD
Olopatadine—S100B—Signaling Pathways—CCR5—atopic dermatitis	1.07e-05	0.000734	CbGpPWpGaD
Olopatadine—S100B—Immune System—CD4—atopic dermatitis	1.04e-05	0.000713	CbGpPWpGaD
Olopatadine—HRH1—Signaling Pathways—CCL22—atopic dermatitis	1.04e-05	0.000712	CbGpPWpGaD
Olopatadine—S100A12—Innate Immune System—IL6—atopic dermatitis	1.02e-05	0.0007	CbGpPWpGaD
Olopatadine—HRH1—GPCR downstream signaling—CCR3—atopic dermatitis	1.02e-05	0.000698	CbGpPWpGaD
Olopatadine—S100A12—Immune System—IL1B—atopic dermatitis	1.02e-05	0.000696	CbGpPWpGaD
Olopatadine—S100A12—Immune System—IL2—atopic dermatitis	1.01e-05	0.000694	CbGpPWpGaD
Olopatadine—HRH1—GPCR ligand binding—CCR5—atopic dermatitis	9.87e-06	0.000676	CbGpPWpGaD
Olopatadine—S100B—Innate Immune System—IL6—atopic dermatitis	9.66e-06	0.000662	CbGpPWpGaD
Olopatadine—S100B—Immune System—IL1B—atopic dermatitis	9.61e-06	0.000659	CbGpPWpGaD
Olopatadine—S100B—Immune System—IL2—atopic dermatitis	9.57e-06	0.000656	CbGpPWpGaD
Olopatadine—S100A12—Immune System—MAPK8—atopic dermatitis	9.32e-06	0.000639	CbGpPWpGaD
Olopatadine—HRH1—Signaling Pathways—CCL27—atopic dermatitis	9.26e-06	0.000635	CbGpPWpGaD
Olopatadine—HRH1—Signaling by GPCR—CCR3—atopic dermatitis	9.24e-06	0.000633	CbGpPWpGaD
Olopatadine—S100B—Signaling Pathways—NFKBIA—atopic dermatitis	9.08e-06	0.000622	CbGpPWpGaD
Olopatadine—HRH1—GPCR downstream signaling—TAC1—atopic dermatitis	9.07e-06	0.000622	CbGpPWpGaD
Olopatadine—HRH1—GPCR downstream signaling—NPS—atopic dermatitis	9.07e-06	0.000622	CbGpPWpGaD
Olopatadine—HRH1—GPCR downstream signaling—CXCR3—atopic dermatitis	8.9e-06	0.00061	CbGpPWpGaD
Olopatadine—S100B—Immune System—MAPK8—atopic dermatitis	8.81e-06	0.000604	CbGpPWpGaD
Olopatadine—HRH1—GPCR downstream signaling—IL5—atopic dermatitis	8.43e-06	0.000578	CbGpPWpGaD
Olopatadine—HRH1—Signaling Pathways—CCL17—atopic dermatitis	8.31e-06	0.000569	CbGpPWpGaD
Olopatadine—HRH1—Signaling by GPCR—NPS—atopic dermatitis	8.24e-06	0.000565	CbGpPWpGaD
Olopatadine—HRH1—Signaling by GPCR—TAC1—atopic dermatitis	8.24e-06	0.000565	CbGpPWpGaD
Olopatadine—HRH1—Signaling by GPCR—CXCR3—atopic dermatitis	8.08e-06	0.000554	CbGpPWpGaD
Olopatadine—HRH1—Class A/1 (Rhodopsin-like receptors)—CXCL8—atopic dermatitis	7.83e-06	0.000537	CbGpPWpGaD
Olopatadine—HRH1—Signaling by GPCR—IL5—atopic dermatitis	7.66e-06	0.000525	CbGpPWpGaD
Olopatadine—HRH1—Signaling Pathways—KIF3A—atopic dermatitis	7.41e-06	0.000508	CbGpPWpGaD
Olopatadine—HRH1—GPCR downstream signaling—CXCL10—atopic dermatitis	7.19e-06	0.000493	CbGpPWpGaD
Olopatadine—HRH1—Signaling Pathways—CMA1—atopic dermatitis	6.7e-06	0.000459	CbGpPWpGaD
Olopatadine—HRH1—Signaling Pathways—CCL11—atopic dermatitis	6.7e-06	0.000459	CbGpPWpGaD
Olopatadine—HRH1—Signaling by GPCR—CXCL10—atopic dermatitis	6.53e-06	0.000448	CbGpPWpGaD
Olopatadine—S100B—Signaling Pathways—CXCL8—atopic dermatitis	6.48e-06	0.000444	CbGpPWpGaD
Olopatadine—HRH1—Signaling Pathways—STAT6—atopic dermatitis	6.3e-06	0.000432	CbGpPWpGaD
Olopatadine—HRH1—GPCR downstream signaling—CCL5—atopic dermatitis	6.19e-06	0.000424	CbGpPWpGaD
Olopatadine—S100B—Signaling Pathways—IL2—atopic dermatitis	6.19e-06	0.000424	CbGpPWpGaD
Olopatadine—HRH1—GPCR ligand binding—CXCL8—atopic dermatitis	5.97e-06	0.000409	CbGpPWpGaD
Olopatadine—S100A12—Immune System—IL6—atopic dermatitis	5.95e-06	0.000408	CbGpPWpGaD
Olopatadine—HRH1—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—atopic dermatitis	5.94e-06	0.000407	CbGpPWpGaD
Olopatadine—S100B—Signaling Pathways—MAPK8—atopic dermatitis	5.7e-06	0.00039	CbGpPWpGaD
Olopatadine—S100B—Immune System—IL6—atopic dermatitis	5.63e-06	0.000386	CbGpPWpGaD
Olopatadine—HRH1—Signaling by GPCR—CCL5—atopic dermatitis	5.62e-06	0.000385	CbGpPWpGaD
Olopatadine—HRH1—GPCR downstream signaling—CCR5—atopic dermatitis	5.58e-06	0.000382	CbGpPWpGaD
Olopatadine—HRH1—Signaling Pathways—CCR3—atopic dermatitis	5.46e-06	0.000374	CbGpPWpGaD
Olopatadine—HRH1—Signaling by GPCR—CCR5—atopic dermatitis	5.06e-06	0.000347	CbGpPWpGaD
Olopatadine—HRH1—Signaling Pathways—NPS—atopic dermatitis	4.87e-06	0.000334	CbGpPWpGaD
Olopatadine—HRH1—Signaling Pathways—TAC1—atopic dermatitis	4.87e-06	0.000334	CbGpPWpGaD
Olopatadine—HRH1—Signaling Pathways—CXCR3—atopic dermatitis	4.77e-06	0.000327	CbGpPWpGaD
Olopatadine—HRH1—Signaling Pathways—IL5—atopic dermatitis	4.52e-06	0.00031	CbGpPWpGaD
Olopatadine—CYP3A4—Metabolism—GLB1—atopic dermatitis	4.11e-06	0.000281	CbGpPWpGaD
Olopatadine—CYP3A4—Metabolism—ADSL—atopic dermatitis	3.94e-06	0.00027	CbGpPWpGaD
Olopatadine—HRH1—Signaling Pathways—CXCL10—atopic dermatitis	3.86e-06	0.000264	CbGpPWpGaD
Olopatadine—S100B—Signaling Pathways—IL6—atopic dermatitis	3.64e-06	0.000249	CbGpPWpGaD
Olopatadine—HRH1—GPCR downstream signaling—CXCL8—atopic dermatitis	3.37e-06	0.000231	CbGpPWpGaD
Olopatadine—HRH1—Signaling Pathways—CCL5—atopic dermatitis	3.32e-06	0.000228	CbGpPWpGaD
Olopatadine—HRH1—GPCR downstream signaling—IL2—atopic dermatitis	3.22e-06	0.000221	CbGpPWpGaD
Olopatadine—HRH1—Signaling Pathways—NGF—atopic dermatitis	3.08e-06	0.000211	CbGpPWpGaD
Olopatadine—HRH1—Signaling by GPCR—CXCL8—atopic dermatitis	3.06e-06	0.00021	CbGpPWpGaD
Olopatadine—HRH1—Signaling Pathways—CCR5—atopic dermatitis	2.99e-06	0.000205	CbGpPWpGaD
Olopatadine—HRH1—Signaling by GPCR—IL2—atopic dermatitis	2.93e-06	0.000201	CbGpPWpGaD
Olopatadine—HRH1—Signaling Pathways—NFKBIA—atopic dermatitis	2.54e-06	0.000174	CbGpPWpGaD
Olopatadine—HRH1—Signaling Pathways—CXCL8—atopic dermatitis	1.81e-06	0.000124	CbGpPWpGaD
Olopatadine—HRH1—Signaling Pathways—IL2—atopic dermatitis	1.73e-06	0.000118	CbGpPWpGaD
Olopatadine—HRH1—Signaling by GPCR—IL6—atopic dermatitis	1.72e-06	0.000118	CbGpPWpGaD
Olopatadine—HRH1—Signaling Pathways—MAPK8—atopic dermatitis	1.59e-06	0.000109	CbGpPWpGaD
Olopatadine—CYP3A4—Metabolism—PPARA—atopic dermatitis	1.33e-06	9.13e-05	CbGpPWpGaD
Olopatadine—HRH1—Signaling Pathways—IL6—atopic dermatitis	1.02e-06	6.96e-05	CbGpPWpGaD
